Financials

News Ideas Discussions Technicals Forecast Seasonals Options Bonds

TEVA fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Teva Pharmaceutical Industries Limited key financial stats and ratios

TEVA price-to-sales ratio is 1.18. The company has an Enterprise Value to EBITDA ratio of 7.48. As of 2023 they employed 37.23 k people.

Statistics

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

‪0.00‬

Price to earnings ratio

Price to cash flow ratio

Currency: USD

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Current

Key stats

—

—

—

—

—

—

—

—

Valuation ratios

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

Profitability ratios

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

Liquidity ratios

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

Solvency ratios

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—